Annual Report 2004-2005 of Sun Pharmaceutical Industries Limited

It is a broadly described annual report of Sun Pharmaceutical Industries Limited in the year of 2004-2005. During the financial year, The Company’s Total Income Rs. 12468 million. Net Profit after Tax for the year Rs. 3057 million. Total income increased 23% over last year. Preference Share Rs. 1/-. Equity shares final Rs. 696. Book value per equity share (Rs. 5 paid up) Rs. 60/-. During the year under review, the Company issued 350,000 Foreign Currency Convertible Bonds (FCCB) of US$ 1,000 each aggregating to US$ 350,000,000 which are convertible into the equity shares of the Company at the option of the Bondholder, at a conversion price of Rs. 729.30 per share of Rs. 5/- each which price was fixed at 50% premium over the closing price of 17^th November 2004.

The Board of Directors are pleased to recommend a preference share dividend @6% p.a. on paid-up amount of preference shares to those preference shareholders of the company whose preference shares are still outstanding and not redeemed and equity dividend at the rate of @75% post bonus (previous year 65% post bonus/130% pre-bonus) for the year ended 31^st March 2005 on the equity share capital.

More Annual Report of Sun Pharmaceutical Industries Limited: